ArticleNeoplasia (New York, N.Y.)2012

Inhibition of COX-2 in colon cancer modulates tumor growth and MDR-1 expression to enhance tumor regression in therapy-refractory cancers in vivo.

Mahbuba Rahman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.